MycoBiomDB – Record Details (MyCo_1576)

Biomarker Record Details

Database ID: MyCo_1576
DB IDMyCo_1576
TitleInvasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease
Year2002
PMID11880959
Fungal Diseases involvedInvasive aspergillosis
Associated Medical ConditionAllogeneic stem cell transplant (SCT)
GenusAspergillus
Speciesspp.
OrganismAspergillus spp.
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveOpportunistic
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameGM
Biomarker Full NameGalactomamman
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationFrance
CohortWe reviewed the medical records for all allogeneic SCT recipients who developed IA during the period from January 1995 through September 1998. All patients had undergone transplantation in the Bone Marrow Transplant Unit at Hoˆpital Saint-Louis (Paris, France). Diagnoses of IA were reviewed by the Hospital Aspergillus Study Group. Diagnoses were made on the basis of the findings of clinical charts, imaging studies (including CT scans), and mycological criteria.
Cohort No.37
Age GroupNone
P Valuep=.002
Sensitivity0.44
Specificity0.87
Positive Predictive Value0.94
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismInvasive aspergillosis (IA) has become one of the leading infectious complications among allogeneic stem cell transplant (SCT) recipients, with a mortality rate of 80%. This dreadful prognosis is related to the severe and protracted immunosuppression experienced by these patients, as well as to the frequent delay in diagnosis and insufficient treatment efficiency and/or limiting toxicity of antifungal agents.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitsSandwich immunocapture ELISA Kit (Platelia Aspergillus; Bio-Rad)
Assay DataNone
Validation Techniques usedELISA
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone